Compare BJDX & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BJDX | SXTC |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8M | 1.8M |
| IPO Year | 2021 | 2017 |
| Metric | BJDX | SXTC |
|---|---|---|
| Price | $5.52 | $1.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 25.3K |
| Earning Date | 05-12-2026 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $249,040.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $0.03 |
| 52 Week High | $7.00 | $6.98 |
| Indicator | BJDX | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 93.74 | 44.27 |
| Support Level | $1.46 | $1.37 |
| Resistance Level | N/A | $1.65 |
| Average True Range (ATR) | 0.54 | 0.11 |
| MACD | 0.38 | 0.02 |
| Stochastic Oscillator | 73.22 | 47.73 |
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.